Literature DB >> 2916951

Neuropsychological and neurological function of human immunodeficiency virus seropositive asymptomatic individuals.

K E Goethe1, J E Mitchell, D W Marshall, R L Brey, W T Cahill, G D Leger, L J Hoy, R N Boswell.   

Abstract

Although individuals with acquired immunodeficiency syndrome (AIDS) are often impaired on a variety of neuropsychological tasks, questions remain as to when neuropsychological decline can be reliably detected during the course of human immunodeficiency virus (HIV) infection. Detailed neuropsychological testing was accomplished on a cohort of 83 immunologically and neurologically intact asymptomatic HIV-infected individuals drawn from a larger pool of 649 US Air Force personnel with HIV antibodies. These asymptomatic subjects were compared with a group of HIV-negative subjects, and no significant differences in neuropsychological functioning were found. No significant neuropsychological differences were found as a function of cerebrospinal fluid abnormalities in these asymptomatic subjects. When data from 13 subjects with immune compromise were included in the analyses, those with abnormal cerebrospinal fluid values performed significantly poorer on a task of verbal memory, suggesting that cognitive dysfunction is antedated by immunological decline. Methodological problems that inhibit specification of the incidence, prevalence, and natural history of HIV-related cognitive impairment are discussed, as are data suggesting that previously published high estimates of the frequency of HIV-related dementia may not be representative of all HIV-infected populations.

Entities:  

Mesh:

Year:  1989        PMID: 2916951     DOI: 10.1001/archneur.1989.00520380029008

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  11 in total

1.  The neuropsychological consequences of HIV infection in drug addicts.

Authors:  S F Cappa; T M Truong; D Vangi; L A Vignolo
Journal:  Ital J Neurol Sci       Date:  1992-09

2.  Beneficial effects of electrostimulation contingencies on sustained attention and electrocortical activity.

Authors:  Max Jean-Lon Chen; Trevor Thompson; Juri Kropotov; John H Gruzelier
Journal:  CNS Neurosci Ther       Date:  2010-10-15       Impact factor: 5.243

Review 3.  Standardized and flexible batteries in neuropsychology: an assessment update.

Authors:  R L Kane
Journal:  Neuropsychol Rev       Date:  1991-12       Impact factor: 7.444

4.  Effect of progression of disease on cognitive performance in HIV/AIDS.

Authors:  Francis Odiase; Olubunmi Ogunrin; Adesola Ogunniyi
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

5.  Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients.

Authors:  G Villa; D Monteleone; C Marra; A Bartoli; A Antinori; F Pallavicini; E Tamburrini; I Izzi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

6.  Neuropsychological deficit in haemophiliacs with human immunodeficiency virus.

Authors:  O Turnbull; M M Saling; K Kaplan-Solms; R Cohn; B Schoub
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

7.  HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers.

Authors:  H J von Giesen; H Hefter; H Roick; S Mauss; G Arendt
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

8.  Neurological and neuropsychological performance in HIV seropositive men without symptoms.

Authors:  R H McAllister; M V Herns; M J Harrison; S P Newman; S Connolly; C J Fowler; M Fell; P Durrance; H Manji; B E Kendall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

9.  Cognitive behavior in asymptomatic (CDC stage II and III) HIV--seropositive intravenous drug users (IVDUs).

Authors:  M Del Pesce; B Franciolini; B Censori; M Bartolini; F Ancarani; E Petrelli; L Provinciali
Journal:  Ital J Neurol Sci       Date:  1993-12

Review 10.  Human immunodeficiency virus type 1 infection of the brain.

Authors:  W J Atwood; J R Berger; R Kaderman; C S Tornatore; E O Major
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.